Enzyme-Linked Immunospot Assay
"Enzyme-Linked Immunospot Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of detection of the number of cells in a sample secreting a specific molecule. With this method, a population of cells are plated over top of the immunosorbent substrate that captures the secreted molecules.
| Descriptor ID |
D058501
|
| MeSH Number(s) |
E01.370.225.500.508 E05.200.500.508 E05.242.551 E05.478.566.350.170.500 E05.478.566.380.360.500 E05.478.583.400.170.500 E05.601.470.350.170.500 E05.601.470.380.360.500
|
| Concept/Terms |
Enzyme-Linked Immunospot Assay- Enzyme-Linked Immunospot Assay
- Assay, Enzyme-Linked Immunospot
- Assays, Enzyme-Linked Immunospot
- Enzyme Linked Immunospot Assay
- Enzyme-Linked Immunospot Assays
- Immunospot Assay, Enzyme-Linked
- Immunospot Assays, Enzyme-Linked
- ELISPOT
|
Below are MeSH descriptors whose meaning is more general than "Enzyme-Linked Immunospot Assay".
Below are MeSH descriptors whose meaning is more specific than "Enzyme-Linked Immunospot Assay".
This graph shows the total number of publications written about "Enzyme-Linked Immunospot Assay" by people in this website by year, and whether "Enzyme-Linked Immunospot Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Enzyme-Linked Immunospot Assay" by people in Profiles.
-
T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. Front Immunol. 2020; 11:575977.
-
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites. Immunol Invest. 2021 Jul; 50(5):562-579.
-
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancer. Cancer Sci. 2017 Jul; 108(7):1452-1457.
-
HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo. PLoS One. 2013; 8(12):e84234.
-
Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines. PLoS One. 2013; 8(9):e75939.
-
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A. 2012 Jun 05; 109(23):9047-52.
-
B-cell responses during primary and secondary dengue virus infections in humans. J Infect Dis. 2011 Nov 15; 204(10):1514-22.
-
Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection. Ann Surg. 2011 Sep; 254(3):512-8; discussion 518-9.